Davenport & CO LLC Boston Scientific Corp Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

A detailed history of Davenport & CO LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Davenport & CO LLC holds 11,274 shares of BSX stock, worth $939,236. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,274

Previous 8,807 28.01%

Holding current value

$939,236

Previous $603,000 43.95%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$67.33 - $77.71 $166,103 - $191,710	2,467 Added 28.01%	11,274 $868,000
Q1 2024 May 03, 2024	BUY	$57.6 - $68.62 $1,958 - $2,333	34 Added 0.39%	8,807 $603,000
Q4 2023 Jan 23, 2024	BUY	$48.64 - $57.81 $1,070 - $1,271	22 Added 0.25%	8,773 $507,000
Q2 2023 Jul 20, 2023	SELL	$49.72 - $54.64 $33,362 - $36,663	-671 Reduced 7.12%	8,751 $473,000
Q1 2023 Apr 27, 2023	SELL	$45.09 - $50.03 $32,825 - $36,421	-728 Reduced 7.17%	9,422 $471,000
Q4 2022 Jan 20, 2023	SELL	$39.56 - $47.22 $596,406 - $711,888	-15,076 Reduced 59.76%	10,150 $0
Q3 2022 Oct 11, 2022	BUY	$36.71 - $109.66 $537,471 - $1.61 Million	14,641 Added 138.32%	25,226 $977,000
Q2 2022 Jul 18, 2022	SELL	$35.24 - $47.1 $10,149 - $13,564	-288 Reduced 2.65%	10,585 $395,000
Q1 2022 May 02, 2022	SELL	$40.9 - $45.1 $29,775 - $32,832	-728 Reduced 6.28%	10,873 $482,000
Q4 2021 Feb 10, 2022	SELL	$38.07 - $44.87 $35,519 - $41,863	-933 Reduced 7.44%	11,601 $493,000
Q3 2021 Oct 14, 2021	SELL	$41.23 - $45.88 $89,798 - $99,926	-2,178 Reduced 14.8%	12,534 $544,000
Q2 2021 Jul 28, 2021	BUY	$38.58 - $44.24 $143,054 - $164,041	3,708 Added 33.7%	14,712 $629,000
Q1 2021 Apr 28, 2021	SELL	$35.27 - $39.67 $138,963 - $156,299	-3,940 Reduced 26.37%	11,004 $425,000
Q4 2020 Jan 13, 2021	BUY	$33.15 - $41.97 $8,486 - $10,744	256 Added 1.74%	14,944 $537,000
Q3 2020 Oct 15, 2020	SELL	$34.44 - $42.23 $20,491 - $25,126	-595 Reduced 3.89%	14,688 $561,000
Q2 2020 Jul 28, 2020	SELL	$30.19 - $39.11 $33,027 - $42,786	-1,094 Reduced 6.68%	15,283 $537,000
Q1 2020 May 05, 2020	BUY	$25.83 - $45.71 $2,841 - $5,028	110 Added 0.68%	16,377 $534,000
Q4 2019 Jan 22, 2020	BUY	$37.87 - $45.37 $35,938 - $43,056	949 Added 6.2%	16,267 $736,000
Q2 2019 Jul 10, 2019	SELL	$34.91 - $42.98 $21,120 - $26,002	-605 Reduced 3.8%	15,318 $658,000
Q1 2019 Apr 17, 2019	BUY	$32.91 - $40.75 $168,992 - $209,251	5,135 Added 47.6%	15,923 $611,000
Q4 2018 Jan 28, 2019	BUY	$31.73 - $39.04 $71,329 - $87,761	2,248 Added 26.32%	10,788 $381,000
Q3 2018 Oct 11, 2018	BUY	$32.83 - $38.63 $71,963 - $84,676	2,192 Added 34.53%	8,540 $329,000
Q2 2018 Jul 09, 2018	BUY	$26.84 - $34.32 $170,380 - $217,863	6,348 New	6,348 $208,000

Others Institutions Holding BSX

# of Institutions

1,448

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $119B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account